PROTIA Inc.

PROTIA Inc.

PROTIA is dedicated to advancing human health and well-being by discovering novel protein targets for disease prediction, early diagnosis, and the development of innovative therapeutics.
We develop cutting-edge in vitro diagnostic (IVD) technologies tailored to the specific needs of our customers and provide products with distinctive competitive advantages. Our product portfolio includes diagnostic kits for human and animal allergies, autoimmune diseases, immune monitoring, next-generation pregnancy testing, and antimicrobial susceptibility testing.
PROTIA Allergy-Q is a multiplex diagnostic platform capable of simultaneously analyzing over 300 allergens. PROTIA Q-AST is a quick antimicrobial susceptibility test utilizing a capacitive sensor, delivering results within hours. In addition, PROTIA offers point-of-care testing solutions that enable immune status assessment using saliva or whole blood.

Allergy Testing, Animal Diagnostics, Autoimmune Disease Testing, Multiplex Testing, Point of Care Testing, Pregnancy Testing, Rapid Tests, Immunoassay Systems, Home Care Testing, Biosensors/Electrodes

Yes

Yes

Direct Sales